Evidence method
Level · gp.fundamentals.debt_to_revenue
387.99% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ANIP · Sep 30, 2021
ANI PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001023024-21-000021General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.10% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-10.38% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-1.73% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
118.48% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-6.84% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.72% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5.39% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History49 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 420.99%
- Current
- 387.99%
- Delta
- -33.00%
- Previous
- 1.92%
- Current
- 1.10%
- Delta
- -0.82%
- Previous
- 0.50%
- Current
- -10.38%
- Delta
- -10.87%
- Previous
- 0.32%
- Current
- -1.73%
- Delta
- -2.05%
- Previous
- 139.09%
- Current
- 118.48%
- Delta
- -20.61%
- Previous
- -31.99%
- Current
- -6.84%
- Delta
- 25.14%
- Previous
- 5.77%
- Current
- 4.72%
- Delta
- -1.05%
- Previous
- 5.85%
- Current
- 5.39%
- Delta
- -0.46%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ANIP Fundamental State →Transitioned To · ANIP Fundamental State →Transitioned To · ANIP BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · ANIP CAPEX_INTENSITY_DECREASED →Transitioned To · ANIP CASH_GENERATION_DECREASED →Transitioned To · ANIP GROWTH_DECREASED →Transitioned To · ANIP INVENTORY_PRESSURE_DECREASED →Transitioned To · ANIP PROFITABILITY_INCREASED →Transitioned To · ANIP R_AND_D_INTENSITY_DECREASED →Transitioned To · ANIP SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.